Patent holdings for IPC class C40B 40/02

Total number of patents in this class: 596

10-year publication summary

25
25
54
52
38
28
23
37
23
9
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Inscripta, Inc., FORMERLY Muse Biotechnology, Inc.
281
38
The Regents of the University of California
20447
20
Massachusetts Institute of Technology
10190
8
Yale University
2478
8
Genentech, Inc.
4058
7
Adimab, LLC
149
7
The Governing Council of The University of Toronto,
1538
7
48Hour Discovery Inc.
10
7
Affinity Biosciences Pty Ltd
10
6
National Research Council of Canada
1565
6
The University of British Columbia
1537
6
President and Fellows of Harvard College
6065
5
Adaptimmune Limited
165
5
CytomX Therapeutics, Inc.
231
5
The Governors of the University of Alberta
874
5
Immunocore Limited
230
5
Nantbio, Inc.
142
5
Centre National de La Recherche Scientifique
10830
4
The Board of Trustees of the Leland Stanford Junior University
6597
4
Takeda Pharmaceutical Company Limited
2722
4
Other owners 434